Tonic to join Huntsworth group as global PR brand
July 20, 2009Medical Communications, Sales and Marketing Huntsworth, Tonic
Independent public relations and communications agency Tonic has been acquired by the Huntsworth group.The Huntsworth group has grown rapidly over …
Jubilant makes solid start to fiscal 2010
July 20, 2009Manufacturing and Production, Research and Development Jubilant
Indian contract research and manufacturing services company Jubilant Organosys shrugged off the effects of the economic downturn with a buoyant …
Drug repositioning a ‘key strategy’ for pharma
July 17, 2009Research and Development Datamonitor, strategy
With increased investment in R&D largely failing to fill drug development pipelines, the pharma industry is looking to get more …
The Trillion Dollar Project: US healthcare reform begins
July 17, 2009Sales and Marketing Obama, US, healthcare, reform
The battle to determine how the US healthcare system will be reformed is heating up, with dozens of interest groups …
Merck signs anticoagulant collaboration
July 17, 2009Research and Development, Sales and Marketing Merck, cv
Merck has continued the trend of big pharma companies signing on the dotted line with small biotech outfits in a …
Bayer to launch OTC omeprazole in Germany
July 17, 2009Sales and Marketing Bayer, OTC
Bayer Vital, the marketing arm of Bayer HealthCare, is to launch the proton pump inhibitor omeprazole as an over-the-counter heartburn …
Effient approved in US
July 17, 2009Research and Development, Sales and Marketing Daiichi Sankyo, Effient, US, lilly
Lilly and Daaichi-Sankyo have gained US approval of their new blood clotting treatment Effient, but hopes of strong sales are …
Depakote’s decline depresses Abbott
July 16, 2009Sales and Marketing Abbott
A rapid drop in sales for epilepsy drug Depakote cast a shadow over second quarter results from Abbott Laboratories. While …
Rheumatoid arthritis delays criticised
July 16, 2009Sales and Marketing NHS, RA
An official report into the treatment of people with rheumatoid arthritis (RA) has criticised a lack of co-ordination between different …
Health minister Lord Darzi resigns
July 16, 2009NHS, healthcare
Lord Darzi has quit his high-profile role as health minister in order to concentrate on his patients, and will in …
NICE bypassed in radical innovation boost
July 16, 2009Research and Development, Sales and Marketing ABPI, Blueprint, NICE, hta
Ministers have sidestepped NICE in their bid to boost innovation in life sciences, and said certain medicines can made available …
Marketers turn their hand to sails at Regatta
July 15, 2009Medical Communications, Sales and Marketing event, pm society, sailing
The sixth annual PM Society Sailing Regatta got off to a crashing start last month, with fine weather conditions and …
Poor antigen yields limiting H1N1 vaccine supplies, says WHO
July 15, 2009Manufacturing and Production, Research and Development h1n1, vaccines
Inadequate production capacity means that the poorest countries in the world will be denied access to vaccines for H1N1 influenza, …
BMS launches cancer website
July 15, 2009Medical Communications, Sales and Marketing BMS, Cancer, digi
Bristol-Myers Squibb has launched a new website for sufferers of chronic myeloid leukaemia (CML), a cancer of the blood. MyCMLCare.com …
Blueprint to fast track innovative drugs and devices
July 14, 2009Research and Development, Sales and Marketing ABPI, Blueprint, NHS
A new 'Blueprint' to put innovation at the heart of the NHS and help support the UK life sciences sector …
Charles River restructures as president sets retirement date
July 14, 2009Research and Development CRO, Charles River
Charles River Laboratories has unveiled a major shake-up its business and sales activities as part of a reorganisation prompted by …
Novartis extends TB donation
July 14, 2009Sales and Marketing Africa, Novartis, TB
Novartis has extended its tuberculosis (TB) drug donation programme to Tanzania. Novartis has already delivered nearly 250,000 TB treatments to …
Clinical trials market worth $50bn in 2008
July 14, 2009Research and Development CRO, strategy
The global clinical trials market topped $50 billion last year and, despite the recent downturn in the fortunes of most …
US approval boosts Plavix competitor
July 14, 2009Research and Development, Sales and Marketing Effient, FDA, US, lilly
US regulator the FDA has approved Lilly and Daiichi Sankyo's Effient, a rival treatment to the world's best-selling blood-thinning drug …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
